Huagai Capital

Synaire engaged in the research and development, production and other related businesses of home ventilators, oxygen concentrators, and non-invasive ventilators.

Shanghai Bioshine Biotechnology Co. is a bitotech company offering biopharmaceutical, medical research, and in vitro diagnostic solutions.

ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vector platform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.

Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturing designs and supporting embedded programs.

Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.

Baijun Biotechnology is a major player in the field of biopharmaceutical R&D services due to its one-stop biotechnology R&D service platform, strong R&D skills, and extensive industry experience.

Ai Sensing Technology is a national high-tech enterprise that focus on the research, development and production of bionic olfactory chips.

Micro Interventional is a company that develops active interventional innovative medical devices. It emphasizes the development of novel medical devices with a product strategy centered on the precise interventional treatment of coronary heart disease and peripheral arterial disease.

Cybernetics is a producer of digital energy solutions and products based on electrical measuring technology.

Utarn Technology is a technology company that specializes in pulsed neural network technology, which is a form of third-generation artificial intelligence. The company focuses on the commercial application of brain-like artificial intelligence, utilizing multi-layer training algorithms to create innovative solutions. One of its key products is the "Zhi Zunbao," an intelligent robot designed to assist individuals in decision-making by mimicking biological brain functions, thereby enhancing efficiency and reducing costs. Utarn Technology also explores advancements in the fields of big entertainment and autonomous driving through its Game Mate and Car Mate series robots, which aim to further integrate intelligent systems into everyday life.

Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.

Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Leaf Biotech is engaged in the research, development, production, and sales of green chemical materials and intermediates. The company specializes in biomass resources and focuses on bio-based polyester materials, specifically Polyethylene Furanoate (PEF) and its key intermediates, such as furandicarboxylic acid (FDCA). In addition to its work in sustainable materials, Leaf Biotech is involved in the creation of green pharmaceuticals and healthcare intermediates, contributing to the development of environmentally friendly solutions. Through these efforts, the company aims to promote sustainability while addressing the needs of various industries.

Dingzhi Biotech specialized in immunology and animal vaccine development. It focuses on innovative and large varieties in the research of covers poultry, livestock, and pets.

Chromai specializes in high-performance intelligent liquid chromatography and medical diagnostic solutions, focusing on simplifying the diagnostic and testing processes. The company employs advanced technologies such as artificial intelligence, Big Data, and the Internet of Things, integrating these with leading analysis and detection methods. Chromai is dedicated to enhancing the fields of health in vitro diagnostics, environmental protection, and scientific instruments. Committed to independent innovation, the company aims to contribute to the revitalization of national industry while providing efficient diagnostic and testing analysis for medical users.

Sangon Biotech Co. is a biotechnology company founded in 2003 as a Sino-foreign joint venture, specializing in the research and development of chemical synthesis of DNA. Over the years, Sangon has established itself as a key player in the global biotechnology market, known for its expertise in DNA synthesis, sequencing, and gene synthesis. The company has invested significantly in its infrastructure, including a manufacturing and industrial base in Songjiang Industrial Park. Sangon offers a wide range of products and services, including molecular biology kits, biochemicals, synthetic genes, oligos, peptide synthesis, enzymes, and laboratory consumables. By providing affordable life science research tools and services, Sangon supports researchers in advancing basic research and product development in the life sciences field.

Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

LIBAOTE is a manufacturing company specializing in the supply of fresh and frozen meat to restaurants and retail outlets. It operates a mobile application that facilitates a streamlined ordering process for catering businesses, enabling them to access high-quality protein products easily. The company manages its own supply chain, which includes overseas supplier resources, independent storage, procurement operations, and quality inspection teams. This comprehensive approach ensures that LIBAOTE can deliver reliable and high-quality meat supplies to its clients efficiently.

Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.

Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Provide systematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.

Carmine Therapeutics is focused on developing a novel gene therapy platform that harnesses extracellular vesicles produced from red blood cells. This innovative approach aims to address limitations associated with traditional viral-based gene therapies, such as immunogenicity, small transgene capacity, and manufacturing challenges. The company's technology is designed to generate a diverse pipeline of gene therapies targeting hematology, oncology, and immunology, offering new treatment options for patients facing these medical conditions. By leveraging this proprietary platform, Carmine Therapeutics seeks to advance the development of a new class of medicines.

Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.

Deepway is a manufacturer of smart vehicles focused on the truck freight market, offering advanced intelligent driving solutions. The company designs heavy-duty trucks characterized by low wind resistance and high-level intelligent driving capabilities. Its vehicles feature a distributed drive system with a modular design that operates on a unified hydrogen and electricity platform. This innovative approach allows the logistics industry to leverage smart freight systems, enhancing efficiency and sustainability in transportation.

MobiDrop develops microfluidic technologies for life sciences and precision medicine. MobiDrop creates cutting-edge instruments, extensive assays, and simple software for ddPCR and single-cell multi-omic platforms. MobiDrop offers ground-breaking solutions for life science research and IVD.

Huojianpai is a commercial aerospace company providing earth-moon space economy and future-oriented deep space exploration.

Kingstar is a fintech service provider focusing on fintech overall solutions for large financial institutions in the industry. Kingstar offers distributed architecture transaction and basic operation support system solutions to the securities industry, as well as risk and internal control management systems that cover the financial securities industry before, during, and after the event. Kingstar focuses on professional fields such as capital markets and enterprise risk management.

Shanghai Perfect Match Flexible Supply Chain Service is an operator for catering and retail fresh food supply chains. Their services include a central kitchen industrial park, fresh delivery, low-temperature storage, intercity transport, and cold chain transportation.

Reistone Biopharma is a clinical stage biopharmaceutical company dedicated to the rapid development of innovative medicines aimed at addressing autoimmune and inflammatory diseases with significant unmet medical needs. The company concentrates on creating treatments for inflammatory bowel diseases, including ulcerative colitis and Crohn's disease, as well as dermatological conditions such as atopic dermatitis. Through global collaborations in research and development, Reistone Biopharma seeks to advance its pipeline of novel therapies to improve patient outcomes in these challenging medical areas.

Clounix is a software startup specializing in high-performance network chips and solutions, particularly focusing on application-specific integrated circuits (ASICs) designed for cloud networking. The company is dedicated to enhancing cloud networking technology through the development of ASICs that facilitate high-speed packet switching. Clounix supports super-internet companies, medium and large enterprises, and network operators in building next-generation networks and data centers. By creating advanced hardware and tailored software that align with cloud-native ecosystems, Clounix plays a crucial role in the evolution of modern networking infrastructure, catering to the needs of global Internet manufacturers and businesses seeking to improve their network capabilities.

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Chuanxin Biotech is an RNA drug research and development service provider.

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

MindRank is an artificial intelligence (AI)-driven drug discovery company focused on streamlining the drug development process. Utilizing its proprietary AI platforms, including PharmKG, Molecule Dance, and Molecule Pro, the company aims to expedite the creation of small molecule medicines that offer unique benefits and improved clinical outcomes. MindRank's technology efficiently recommends cost-effective synthesis routes for various compounds and supports drug design, enabling clients to develop effective pharmaceuticals more quickly and efficiently. Through its innovative approach, MindRank seeks to transform the landscape of drug discovery.

Beijing Sudo Technology provides privacy protection technical services from the perspective of systematic comprehensive engineering.

Datong Insurance is a professional third-party financial insurance service organization. Datong’s subsidiaries include Datong Insurance Sales Service Co., Ltd., Beijing Datong Insurance Brokers Co., Ltd., among which Datong Insurance Sales Service Co., Ltd. is approved by the China Insurance Regulatory Commission. The first national insurance professional sales and service organization approved to be established. At present, the Datong service network has covered more than 20 provinces and municipalities across the country.

NeuraMatrix is a developer of advanced brain-computer interface technology that focuses on enhancing human-computer interaction through a comprehensive hardware-software platform. The company aims to facilitate research in brain science and neurological diseases, offering innovative solutions for diagnosis, treatment, and drug development. NeuraMatrix recently secured substantial funding to support its initiatives, which will be allocated toward upgrading research and development equipment, mass production of chips, product iterations, and market promotion. By leveraging its technology, NeuraMatrix seeks to unlock significant commercial applications in the field of neuroscience and improve the integration of users with technological systems.

H.Extract is a company focused on the research, development, promotion, and sales of pharmaceutical ERP solutions. As a leading brand in China's pharmaceutical distribution sector, H.Extract has implemented its Cloud ERP System in over 40,000 pharmacies nationwide. The company formed a strategic partnership with Tencent Cloud and WeChat Pay in 2016 to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract leverages its technical expertise and management skills to cater to a diverse client base, including major players in the pharmaceutical sector such as Harbin Pharmaceutical Group and Hainan Zhangzhongjing Dispensary. The company's commitment to innovation and high-quality service aims to streamline operations within the pharmaceutical supply chain.

Meike Solar focuses on the research and development of solar photovoltaic polycrystalline silicon wafers and operates integrated monitoring systems and equipment to facilitate intelligent manufacturing processes, permitting itself to make products efficiently at a reduced cost.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience, the company supports drug discovery and development through a comprehensive range of services, including molecular assessment, cGMP clinical trial materials production, commercial-scale manufacturing, and various process developments. JOINN Biologics also provides analytical and formulation development, along with documentation support for regulatory filings. The company aims to accelerate the development of high-quality biologics, thereby addressing patient needs and delivering lasting value to the biotech and biopharmaceutical sectors. By owning full intellectual property for cell line engineering, JOINN Biologics helps mitigate intellectual property issues faced by research and development organizations.

PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy, the body's most versatile mechanism for natural cellular degradation.

Xianghuanji is a marketing company that operates an online platform dedicated to cell phone rental services. The platform enables clients to rent cell phones through a subscription model, streamlining the process of obtaining mobile devices on a rental basis. By utilizing a single platform for these services, Xianghuanji simplifies the experience for users seeking flexible access to cell phones without the commitment of purchase.

Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.

“To Translate Novel Modality into Reality”. Duality Biologics was founded in January 2020 by Dr. John Zhu, a well-respected investor in the healthcare industry. Duality Bio is committed to developing novel modality drugs to fulfill the unmet medical needs for patients worldwide. Focusing on the oncology and autoimmune diseases, the company has built a novel internal pipeline including nearly 10 Best-in-Class and First-in-Class bispecific antibody and Antibody-Drug Conjugate (ADC) drugs, of which several drug candidates are in the IND stage. The company has successfully built the next-generation ADC platform with global intellectual property rights. The value of this platform has been validated by a number of drug candidates under development.

Zhongke Jiuyuan focuses on the manufacturing and sales of key materials such as polyimide films and slurries.

Reliable Med is a medical device developer.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Synaptic Medical Inc. is a medical device company that develops and commercializes products aimed at treating cardiac arrhythmias and other cardiovascular diseases. Founded in 2005, the company operates from its headquarters in St. Paul, Minnesota, and has an additional office in Beijing, China. Synaptic Medical specializes in cardiac electrophysiology products, including bipolar pacing systems, fixed curve and deflectable diagnostic catheters, pulmonary vein mapping catheters, and ablation technologies. The company's mission is to create innovative, cost-effective, and clinically advanced solutions that enhance treatment options for physicians and their patients.

Shanghai ANE Logistics Co., Ltd., founded in 2010 and based in Hangzhou, China, specializes in trucking and logistics services, focusing on less than truckload (LTL) operations. The company has pioneered a franchise model within China's LTL industry, establishing a comprehensive national delivery network that includes approximately 5,000 franchised stores. To support its logistics operations, Shanghai ANE Logistics operates 50 distribution centers and utilizes self-operated sorting centers, along with contracted line-haul trucks for efficient transportation. This innovative approach enables the company to effectively manage logistics and distribution across the country.

Innolake Biopharm is a clinical-stage biotechnology company specializing in the development of therapeutic drugs aimed at treating oncology and autoimmune diseases. The company is actively engaged in research and development, focusing on innovative solutions to address tumors and immune system disorders. With an extensive product development pipeline, Innolake Biopharm seeks to improve patient health outcomes by delivering advanced treatment options.

Gene+ operates in the biotechnology industry, focusing on genetic research and development. The company offers a range of services including gene panel development and mutation detection in peripheral blood. Gene+ also provides Next Generation Sequencing (NGS) services, contributing to the field of oncology. Their Smart Laboratory, known as Gene+sLab, is another key aspect of their operations. The company is also involved in tumor gene detection, offering precision medicine series, tumor whole process monitoring, and early tumor screening and diagnosis services.

GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. Utilizing high-throughput sequencing technology and intelligent algorithm analysis, GensKey addresses traditional challenges such as low detection rates, lengthy processes, and diagnostic accuracy. This innovative approach allows for timely and precise diagnoses for patients suffering from severe infections, ultimately improving patient outcomes by facilitating quicker access to appropriate medical interventions.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

MicuRx Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing antibiotics to address drug-resistant bacterial infections. Founded in 2007 and headquartered in Palo Alto, California, the company has established a hybrid business model that leverages U.S. research and development alongside cost-effective scientific resources in China. MicuRx's product lineup includes MRX-I, an oral antibiotic targeting multi-drug resistant gram-positive pathogens, and its intravenous prodrug form, MRX-IV. Additionally, the company offers MRX-V, an injectable antibiotic for gram-negative bacteria, and MRX-VIII, a polymyxin for gram-negative infections. The company is also working on a pipeline of antibacterial drugs aimed at combating both gram-positive and gram-negative bacterial pathogens. MicuRx's subsidiary, Shanghai MicuRx, is responsible for commercializing its agents in China while global clinical studies continue.

AccuMedical is a full-line product company in the field of neurological intervention, headquartered in Beijing with an R&D center located in California. It develops and produces medical device products for the treatment of aneurysms, preventing, and treating bleeding diseases caused by the rupture of vascular aneurysms.

Shukun Technology is a Chinese healthcare company, established in 2017 and based in Beijing, that focuses on developing diagnostic systems utilizing machine learning and artificial intelligence. The company specializes in assisting medical professionals with the diagnosis of cardiovascular diseases and tumors by employing deep learning algorithms to analyze medical images. This technology enables the automatic identification of lesions and the generation of diagnostic reports, thereby enhancing the efficiency of the diagnostic process for doctors and improving the quality of care provided in primary hospitals.

Immvira, founded in Shenzhen, China, in May 2015 by a group of prominent professors from various universities, is focused on developing biopharmaceutical technology in the field of immunotherapy. The company specializes in creating oncolytic viruses and vector-type approaches aimed at treating cancer. Its primary product is a genetically engineered Oncolytic Herpes Simplex Virus, which is designed to target metastatic tumors or tumors that are difficult to access by direct injection. By leveraging this innovative technology, Immvira aims to provide more effective treatment solutions for patients suffering from cancer.

Galaxis technology group, founded in 2014, is a high-tech enterprise focusing on providing integrated logistics automation and robotics solutions and one-stop service. It brings together first-class technical experts and teams from home and abroad. With years of experience in logistics and technical accumulation, has more than hundreds of software copyright, and the national patent, formed the consulting including logistics system planning, software development, system integration, operation guidance, and multi-layer shuttle, high speed lift, AGV, sorting system such as the core research and development of high-end equipment manufacturing as a whole solution, the construction of logistics system can provide customers with one-stop service. High standards, refined product and service quality have kept the company in a leading position in the industry.The application cases are widely applied in more than 10 industries, such as medicine, e-commerce, clothing, books, rail,transit, automobile, etc., and more than 150 large and medium-sized modern logistics centers and production three-dimensional warehouses have been constructed, with the total investment of the project exceeding 20 billion rmb. Headquartered in Jiaxing, the group has technology r&d centers in Germany and Austria, subsidiaries or factories in eight cities of Shanghai, Beijing, Guangzhou, Wuhan, Jiaxing, Wuxi, Chengdu and Kunming. Their vision is to become the world's leading supplier of logistics robots and high-end equipment, technical service providers and system integrators. Focus on customers, continuous innovation, let the world do not hard logistics!

Quantinfo Technology is a financial information and technology company based in Shanghai, China, founded in 2014. The company specializes in providing quantitative trading solutions for financial institutions, focusing on electronic trading services that include market data cleansing, trading strategy development, execution, and risk management. Its flagship products, FinOne Backtesting and FinOne Quant Trading, offer tools for developing quantitative trading strategies, managing historical market data, and conducting backtesting. The firm serves various markets, including income, Forex, and precious metals, and counts major banks and financial institutions among its clients, such as ICBC and CITIC Securities. Through its comprehensive offerings, Quantinfo Technology enables clients to enhance their trading capabilities and achieve better market outcomes.

Tcpjw offers invoicing supply chain platforms in China. Using big data, cloud and fintech innovation, Tcpjw creates a transparent online trading platform for enterprises to manage efficiency.

Alebund Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapies for renal diseases and related chronic conditions. The company specializes in the research, development, regulatory approval, and commercialization of medicines aimed at treating various kidney diseases, including chronic kidney disease, complications associated with dialysis, nephropathy, diabetic kidney disease, and autosomal dominant polycystic kidney disease. With a diversified and balanced pipeline of drug candidates, Alebund Pharmaceuticals aims to provide comprehensive and high-quality solutions for patients suffering from renal diseases.

Chifang Information Technology specializes in intelligent investment and trading platforms.

Kafang is a leading provider of electronic trading solutions in the Chinese capital market, specializing in quantitative trading and transaction systems for financial services and hedge funds. The company focuses on developing advanced algorithmic models that facilitate automated and complex dark pool trading, catering to the needs of institutional clients such as pension funds, investment banks, mutual funds, and hedge funds. By leveraging advanced quantitative methodologies and emerging technologies, Kafang delivers efficient and reliable transaction solutions, enhancing trading execution for its clients in a competitive financial landscape.

JOINN Biologics is a California Bay Area-based company specializing in contract development and manufacturing services for biologics and advanced therapies. With over 20 years of experience, the company supports drug discovery and development through a comprehensive range of services, including molecular assessment, cGMP clinical trial materials production, commercial-scale manufacturing, and various process developments. JOINN Biologics also provides analytical and formulation development, along with documentation support for regulatory filings. The company aims to accelerate the development of high-quality biologics, thereby addressing patient needs and delivering lasting value to the biotech and biopharmaceutical sectors. By owning full intellectual property for cell line engineering, JOINN Biologics helps mitigate intellectual property issues faced by research and development organizations.

Yijiaoyoupei is a teacher learning platform, dedicated to helping the teacher group complete professional training, so that each teacher can easily improve their professional level; there are many training topics in the platform. The workshop is equipped with various learning resources. Users only need to select the corresponding topics according to their needs to start the training.

Genome Wisdom is a gene-based precision medical technology service provider that provides high-throughput, high-precision genomic data solutions for clinical & personal genomes, including disease molecular mechanisms based on multi-omics integration analysis, and oncology treatment dynamics. Design, implementation and industrial incubation of scientific research projects such as surveillance and tumor space molecular pathology analysis.

iSoftStone is China's leading smart city technology service and operator. Focus on the use of emerging technologies such as big data, cloud computing, Internet of Things, artificial intelligence, etc., based on urban development needs, precipitating urban data, providing integrated design, construction and operation services for digital and intelligent cities in China.

Founded in September 2011, Life Real focuses on developing and producing life sciences and clinical diagnostic products. The company has developed a range of fully automated integrated molecular diagnostic equipment designed to meet the scientific research needs of the life sciences sector. Life Real is committed to providing cost-effective clinical diagnostic solutions and is currently undertaking necessary product certification processes. Its offerings include a variety of laboratory equipment such as autoclavable pipettes, pipette controllers, micro UV spectrophotometers, and geneReady homogenizers. These products are designed to enhance the safety and convenience of laboratory experiments and testing. Life Real's products are compliant with RoHS standards and CE certified, with options for OEM and ODM cooperation available to meet specific customer requirements.

Zuodashi specializes in the research and development, production, and sales of food and compound seasonings. The company focuses on creating a diverse range of condiments designed to enhance the flavor of takeaway food. In addition to its condiment offerings, Zuodashi has developed software that assists restaurants in managing takeaway applications through a unified platform. This combination of product and technology aims to improve the overall experience for both food providers and consumers.

OnVideo offers professional-level cloud video creation platform where everyone can start to create professional-grade movies.

MGI Tech is a company focused on providing effective and affordable healthcare solutions through the development of advanced life science tools. The company produces clinical high-throughput gene sequencers, along with essential equipment, consumables, and reagents that support life science research and healthcare. MGI Tech's multi-omics platforms encompass genetic sequencing, mass spectrometry, medical imaging, and laboratory automation. By offering real-time, comprehensive systems designed for precision medicine and healthcare, MGI Tech aims to enhance healthcare delivery and drive innovation in digital health.

GeneQuantum Healthcare (Suzhou) Co., Ltd. is a high-tech company specializing in the research and development of innovative biotherapeutics, particularly in the field of anti-tumor therapies. Founded in August 2013 in Suzhou Industrial Park, the company has established a world-class bio-conjugation technology platform that utilizes a ligase-dependent conjugation method. This advanced technology significantly enhances the therapeutic window for developing a series of next-generation Antibody-Drug-Conjugates (ADCs). GeneQuantum is actively working on advancing its ADC candidates towards Investigational New Drug (IND) applications in both the United States and China, while also focusing on expanding its product pipeline to address unmet medical needs in cancer treatment.

Kexin Health is a tumor screening, diagnosis, treatment and rehabilitation institution. It is committed to building a platform for oncology hospital chain hospitals that integrates modern medical technology and traditional Chinese medicine treatment, integrating tumor clinical, teaching and scientific research.

Xiaoyu Link is an online video conference solution provider. Xiaoyu Link plans to use the proceeds to enhance its sales and marketing efforts, as well as carrying out research in new products and technologies.

Zhi Teng Education is a new concept concept for the development, training, promotion and joining of extracurricular quality potential of primary school students. It has been intensively researching children's characteristic education courses for many years, and has been continuously innovating for the special education and training programs for 4-12 years old primary school students. The most advanced education and teaching theory, the development of cutting-edge training aids and teaching models, and strive to be unique in the industry with its outstanding performance, so that tens of thousands of students become profound and wise.

Shukun Technology is a Chinese healthcare company, established in 2017 and based in Beijing, that focuses on developing diagnostic systems utilizing machine learning and artificial intelligence. The company specializes in assisting medical professionals with the diagnosis of cardiovascular diseases and tumors by employing deep learning algorithms to analyze medical images. This technology enables the automatic identification of lesions and the generation of diagnostic reports, thereby enhancing the efficiency of the diagnostic process for doctors and improving the quality of care provided in primary hospitals.

Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.

Aidong Super AI is an industrial Internet services company that leverages artificial intelligence to enhance equipment management and industrial security. Its offerings include a range of products and solutions aimed at improving operational efficiency and safety. The company focuses on digitizing and optimizing fleet operations, particularly in managing forklifts, which allows for increased transparency and management effectiveness. Among its key products are systems designed to improve vehicle efficiency, AI-driven sanitation monitoring, and technology for identifying runners' gait. By addressing operational challenges related to personnel and asset efficiency, Aidong Super AI positions itself as a valuable partner for businesses seeking to enhance their industrial operations.

EdiGene Inc. is a biotechnology company based in Beijing, China, with additional offices in Guangzhou and Cambridge, Massachusetts. Founded in 2015, EdiGene specializes in the development of advanced genome editing technologies aimed at addressing various genetic diseases and cancer. The company focuses on both ex vivo and in vivo gene-editing therapies, utilizing proprietary platforms for modifying genetic information in human cells. Their innovative approaches include gene knockout, knock-in, and targeted mutations, which facilitate the creation of safer and more effective gene therapies. EdiGene also supports pharmaceutical research by providing high-throughput genome screening and drug target analysis, enhancing drug discovery efforts in the industry. Through its commitment to translating genome editing into therapeutics, EdiGene aims to improve human health outcomes and advance scientific research.

Ruizhi Hechuang Technology is a big data integration service provider. Ruizhi Hechuang Technology designs big data analysis and application technology, carries out key technological breakthroughs in industries, formulates important technical standards, and gathers and trains technological talents urgently needed by the industry. The company provides significant value, high intelligence, and the latest digital solutions to help financial institutions digitally change.

Songxiaocai operates a mobile Internet platform that provides vegetable picking and distribution and after-sales service business to business services for small and medium size retailer.

Shukun Technology is a Chinese healthcare company, established in 2017 and based in Beijing, that focuses on developing diagnostic systems utilizing machine learning and artificial intelligence. The company specializes in assisting medical professionals with the diagnosis of cardiovascular diseases and tumors by employing deep learning algorithms to analyze medical images. This technology enables the automatic identification of lesions and the generation of diagnostic reports, thereby enhancing the efficiency of the diagnostic process for doctors and improving the quality of care provided in primary hospitals.

Karaku is a Gaming Platform.

Kalaku is an indoor entertainment, new retail and marketing interaction services company.

Xianlepin is a purchase retail platform.

Bairong is an independent technology platform based in China that offers professional financial information services primarily to large companies in the financial services industry. Utilizing artificial intelligence, cloud computing, and blockchain technology, Bairong focuses on exploring innovative applications that enhance the digital transformation of financial institutions. The company aims to empower these institutions to innovate while also promoting financial inclusion. Through its AI-driven solutions, Bairong supports financial organizations in navigating the evolving landscape of technology in finance.

13 Month Culture is a music production and related services company that specializes in various aspects of the music industry. The company offers services including music production, music creation, and artist management. Additionally, it is involved in the operation of music festivals, focusing on the incubation and cultivation of new music artists. By coordinating music events and providing comprehensive support to artists, 13 Month Culture plays a significant role in the development and promotion of emerging talent within the music landscape.

Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment, and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.

IPao is an internet car rescue platform. They provide small road assistance businesses and provide services such as towing, tire changes, battery charging, and more, enabling users to call for road assistance.

Louxiaoyi offers courier distribution services that incorporate office buildings. They solve the problem of sending and receiving express delivery in office buildings through a combination of online and offline methods. They use the WeChat light application to realize the user's express delivery notification, self-service, and various value-added services.

Nine strong biological is an in-vitro diagnostic reagent and biochemical detection instrument developer, specializing in the development and production of in vitro diagnostic products, its products include small, dense low-density lipoprotein cholesterol, fibronectin, retinol binding protein.

Yiwai publishes articles and videos introducing art to the public.

Cool College is a SaaS enterprise intelligent & digital management learning platform for corporate and employee training services.

Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

SWS Hemodialysis Care Co., Ltd. has been a leader in blood purification since its founding in 2001. The company operates in four main areas: manufacturing blood purification equipment, producing consumables, providing an Advanced Hemodialysis Management System, and managing a network of dialysis centers. SWS focuses on delivering comprehensive medical solutions for patients with chronic kidney disease, showcasing its commitment to patient welfare through safe and effective products and services. The organization emphasizes innovation, holding nearly 200 patents and recognized as a national demonstration enterprise for technological advancement. SWS has established national and industry standards, contributing significantly to the field. Its high-quality products, which are CE marked and certified under ISO 13485:2016, have been installed in numerous medical facilities worldwide, benefiting patients in over 80 countries. SWS's dedication to enhancing patient wellness is reflected in its ongoing commitment to advanced integrated blood purification technologies and its partnerships with top-tier hospitals and medical institutions.

No Panda Culture (Bukongwenhua) is a Shanghai-based entertainment and culture agency.

Suzhou Lonwin Medical Systems is a manufacturer specializing in medical imaging equipment aimed at enhancing the affordability and effectiveness of medical diagnostics and treatment. The company produces a range of products, including magnetic resonance imaging (MRI) systems, computerized tomography (CT) systems, and direct digital x-ray imaging systems. Lonwin's offerings span four key areas: magnetic resonance imaging, radiography, imaging-related products, and interventional therapy-related products. By providing advanced medical imaging solutions, Lonwin enables healthcare practitioners and hospitals to deliver high-quality, efficient, and cost-effective imaging services to their patients.

Sino Vision is a medical device manufacturing company based in China. The company provides X-ray computed tomography equipment, sROBOT robot CT navigation system, and sAI intelligent imaging solutions. Sino Vision was established in 2012.